Label prescribing information for dabigatran (Pradaxa, Boehringer Ingelheim) capsules has been updated
to affirm that the 150-mg twice-daily dose is superior to warfarin in reducing ischemic and hemorrhagic strokes in
patients with nonvalvular atrial fibrillation.
Read the complete post at http://www.modernmedicine.com/modernmedicine/Top+News/Dabigatran-prescribing-information-is-updated/ArticleStandard/Article/detail/777673?ref=25
Posted
Jun 14 2012, 12:00 AM
by
ModernMedicine